<DOC>
	<DOCNO>NCT01131884</DOCNO>
	<brief_summary>Study design evaluate efficacy oral fosamax prevention osteoporosis acute spinal cord injury . Efficacy measure duel energy X-Ray absorptiometry ( DEXA ) scan every 6 month . Patients complete 3 visit , screen , 6 month , 12 month require take oral fosamax versus placebo weekly .</brief_summary>
	<brief_title>Pilot Study Fosamax Spinal Cord Injury</brief_title>
	<detailed_description>The project fund August 13 , 2009 award one trainee , Dr. Matthew Abraham , PGY3 program IRB approval obtain much time effort February 24 , 2010 . We follow protocol far recruit one patient September 19 , 2011 complete study encounter many unexpected obstacle recruit patient study . The main obstacle spine surgeon ' refusal start study drug month surgery fear complication wound heal . Secondly , appropriate eligible patient try recruit decline participate . We unable recruit patient study hence study close . The one patient recruit complete study . Since one subject study , conclusion draw .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Alendronate</mesh_term>
	<criteria>American Spinal Cord Injury Association ( ASIA ) A American Spinal Cord Injury Association ( ASIA ) B Spinal Cord Injury History hypersensitivity alendronate bisphosphonates esophageal abnormality inability sit/stand upright 30 minute creatinine clearance le 35 milliliters/minute hypothyroidism malignancy pregnancy prolong steroid use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>ASIA A ASIA B Spinal Cord Injury</keyword>
</DOC>